These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32468237)

  • 1. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis.
    Li Q; Dai Z; Xia C; Jin L; Chen X
    Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109].
    Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228
    [No Abstract]   [Full Text] [Related]  

  • 3. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
    Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
    J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
    Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
    Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of MALAT1 inhibits migration and invasion by sponging miR‑1‑3p in prostate cancer cells.
    Dai X; Liang Z; Liu L; Guo K; Xu S; Wang H
    Mol Med Rep; 2019 Oct; 20(4):3499-3508. PubMed ID: 31485645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.
    Yang C; Shen S; Zheng X; Ye K; Sun Y; Lu Y; Ge H
    FASEB J; 2019 Sep; 33(9):10490-10504. PubMed ID: 31311326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Kong Q; Qiu M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma.
    Yu L; Shao X; Huo L; Zhang T
    Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.
    Pan J; Zang Y
    Dig Dis Sci; 2022 Jul; 67(7):2936-2947. PubMed ID: 34313922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ-MALAT1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/KAT6B axis.
    Yang FS; Gong SX; Qiu DD
    Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
    Sun R; Zhang L
    Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
    Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M
    Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.